MedTrace Logo

Antibiotic Therapy for Early Onset Neonatal Sepsis

NCT03932123 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-04-20

No results posted yet for this study

Summary

Antibiotic therapy for early onset neonatal sepsis recommended by international guidelines and relevant studies is only kind of treatment regimen that penicillin G/ penicillin/ampicillin combined with gentamicin as the first-line treatment regimen. However, it is not applicable to the clinical practice in many countries and regions. We aim to study efficacy and safety of antibiotics in the treatment of early onset neonatal sepsis.

Conditions

  • Early Onset Neonatal Sepsis

Interventions

DRUG

Piperacillin and tazobactam, azlocillin, latamoxef, meropenem, vancomycin，cefotaxime

Efficacy and safety of antibiotics

Sponsors & Collaborators

  • Tianjin Central Hospital of Gynecology Obstetrics

    collaborator OTHER

  • Shandong Provincial Hospital

    collaborator OTHER_GOV

  • Qianfoshan Hospital

    collaborator OTHER

  • Shandong University

    lead OTHER

Eligibility

Min Age
0 Days
Max Age
3 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-05
Primary Completion
2025-10-31
Completion
2025-12-31
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03932123 on ClinicalTrials.gov